Navigation Links
Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
Date:2/27/2008

LITTLE ROCK, Ark., Feb. 27 /PRNewswire/ -- Cauley Bowman Carney & Williams, PLLC announces an investigation into the proposed acquisition of CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI). On February 26, 2008, CollaGenex announced that it has entered into a definitive merger agreement with an affiliate of Galderma Pharma S.A. Under the terms of the proposal, CollaGenex's shareholders would receive $16.60 per share in cash for each share owned. This price per share represents an approximately 33% premium over the stock's closing price of $16.23 prior to announcement of the acquisition.

Cauley Bowman Carney & Williams, PLLC

Cauley Bowman is a national law firm that represents investors in securities fraud and corporate governance class actions. It is one of the country's premier firms in the area of securities fraud having recovered billions of dollars for defrauded investors and secured significant corporate governance reforms. Cauley Bowman maintains in-house finance, forensic accounting specialists and extensive trial experience.

If you are a current shareholder of CollaGenex Pharmaceuticals, Inc. and would like to be advised of your rights in this matter, you may contact Cauley Bowman Carney & Williams, PLLC at the phone number below.

CONTACT

Darrin L. Williams, Esq.

Randall K. Pulliam, Esq.

Kristi Gray

501-312-8500

1-888-551-9944

info@cauleybowman.com


'/>"/>
SOURCE Cauley Bowman Carney & Williams, PLLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
2. DuPont Leaders Brief Investors on Agriculture Businesses
3. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
4. Thermo Fisher Scientific to Present at Investor Conferences
5. Modigene to Present at the Roth 2007 New York Investor Conference
6. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
9. Suntech to Attend Upcoming Investor Conferences and Industry Events
10. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
11. American Oriental Bioengineering Announces Participation in September Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... DuPont Pioneer and recently formed CasZyme, ... into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The goal ... editing across all applications. , Under the terms of the agreement, Pioneer will ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces ... addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market ... hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):